期刊
SCIENCE
卷 353, 期 6299, 页码 594-598出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aaf8993
关键词
-
资金
- Deutsche Forschungsgemeinschaft (DFG) [CH1098-1/1, SFB860-TP A5]
- European Strategy Forum on Research Infrastructures (ESFRI)
- Bundesministerium fur Bildung und Forschung (BMBF) [05K2013-624]
The proteasome is a validated target for anticancer therapy, and proteasome inhibition is employed in the clinic for the treatment of tumors and hematological malignancies. Here, we describe crystal structures of the native human 20S proteasome and its complexes with inhibitors, which either are drugs approved for cancer treatment or are in clinical trials. The structure of the native human 20S proteasome was determined at an unprecedented resolution of 1.8 angstroms. Additionally, six inhibitor-proteasome complex structures were elucidated at resolutions between 1.9 and 2.1 angstroms. Collectively, the high-resolution structures provide new insights into the catalytic mechanisms of inhibition and necessitate a revised description of the proteasome active site. Knowledge about inhibition mechanisms provides insights into peptide hydrolysis and can guide strategies for the development of next-generation proteasome-based cancer therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据